Fairfax India Holdings Corporation: First Quarter Financial Results

In This Article:

Fairfax India Holdings Corporation
Fairfax India Holdings Corporation

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

(Note: All dollar amounts in this press release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board ("IFRS?"), except as otherwise noted, and are unaudited. This press release contains certain non-GAAP and other financial measures, including book value per share, and cash and marketable securities, that do not have a prescribed meaning under IFRS and may not be comparable to similar financial measures presented by other issuers. See "Glossary of non-GAAP and other financial measures" in the company's Interim Report for the three months ended March 31, 2024 for further details.)

TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Fairfax India Holdings Corporation (TSX: FIH.U) announces a net loss of $293.5 million in the first quarter of 2024 ($2.17 net loss per diluted share), compared to a net loss of $55.5 million in the first quarter of 2023 ($0.40 net loss per diluted share). Book value per share decreased 10.1% to $19.65 at March 31, 2024, from $21.85 at December 31, 2023, primarily due to unrealized losses recorded on the company's listed investments.

Highlights for the first quarter of 2024 included the following:

  • Net change in unrealized losses on investments of $410.9 million principally from decreases in the fair values of the company's listed investments of $273.3 million, including IIFL Finance ($177.8 million), CSB Bank ($63.4 million), IIFL Securities ($22.4 million) and 5paisa ($5.5 million), and private company investments of $20.3 million, including Sanmar ($30.5 million) (primarily due to a decrease in the publicly traded share price of its subsidiary, Chemplast) and NCML ($5.2 million). These unrealized losses were partially offset by an increase in the fair value of the company's investment in the private company Seven Islands ($7.2 million). Net change in unrealized losses on investments also included reversals of prior period gains upon the sales of NSE shares ($117.2 million).

  • Net realized gains on investments of $116.9 million primarily related to sales of NSE shares for gross proceeds of $132.3 million (11.0 billion Indian rupees), resulting in realized gains since inception of $117.1 million.

  • The company continued to buy back shares under its normal course issuer bid and during the first three months of 2024 purchased for cancellation 246,062 subordinate voting shares at a net cost of $3.6 million ($14.72 per subordinate voting share).

  • Fairfax India is in strong financial health, with cash and marketable securities at March 31, 2024 of approximately $210 million, prior to completing sales of its remaining investment in NSE for gross proceeds of $56.7 million (4.7 billion Indian rupees) in April 2024.